RecruitingPhase 4NCT07662408

Comparison of Norepinehrine Versus Phenylepherine Infusion for Prevention of Post-spinal Hypotension

Comparison of Norepinephrine Versus Phenylephrine Infusion for Prevention of Hypotension Due to Subarachnoid Block in Elderly Patients Undergoing Orthopedic Hip Surgery:A Prospective Randomized Trial


Sponsor

Sohag University

Enrollment

62 participants

Start Date

May 22, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective randomized double-blinded clinical trial aims to compare the efficacy and hemodynamic effects of prophylactic norepinephrine infusion versus phenylephrine infusion for prevention of spinal anesthesia-induced hypotension in elderly patients undergoing elective orthopedic hip surgery under subarachnoid block. Sixty-two patients aged 60 years or older will be randomly assigned into two equal groups to receive either norepinephrine infusion (8 µg/min) or phenylephrine infusion (100 µg/min) immediately after spinal anesthesia. The primary outcome is the mean heart rate during vasopressor infusion, while secondary outcomes include incidence of hypotension, severe hypotension, bradycardia, reactive hypertension, intraoperative fluid requirements, blood loss, transfusion requirements, and postoperative nausea and vomiting. Hemodynamic parameters will be monitored throughout surgery to evaluate the safety and effectiveness of both vasopressor strategies.


Eligibility

Min Age: 60 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Norepinephrine and a drug called Phenylephrine for people with orthopedic hip sugery in eldely patients and patients undergoing orthopedic hip surgery under spinal anesthesia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNorepinephrine

norepinephrine infusion at 8 µg/min. Infusion will continue for 45 minutes after spinal anesthesia.

DRUGPhenylephrine

phenylephrine infusion at 100 µg/min. Infusion will continue for 45 minutes after spinal anesthesia.


Locations(1)

Sohag university hospital

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07662408